How have REVBW shares performed in 2024?

Revelation Biosciences' stock was trading at $0.0106 at the start of the year. Since then, REVBW stock has increased by 34.9% and is now trading at $0.0143. View the best growth stocks for 2024 here .

Are investors shorting Revelation Biosciences?

Revelation Biosciences saw a decrease in short interest in April. As of April 15th, there was short interest totaling 1,300 shares, a decrease of 23.5% from the March 31st total of 1,700 shares. Based on an average daily trading volume, of 78,500 shares, the days-to-cover ratio is currently 0.0 days. View Revelation Biosciences' Short Interest .

How do I buy shares of Revelation Biosciences?

Shares of REVBW stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

NASDAQ:REVBW

Revelation Biosciences (REVBW) Stock Price, News & Analysis

→ His win rate puts Warren Buffett to shame… (From Investing Daily) (Ad)

Free REVBW Stock Alerts

$0.01

0.00 (0.00%)

(As of 04/26/2024 ET)

Compare

Today's Range: $0.0108
▼
$0.0143
50-Day Range: $0.01
▼
$0.03
52-Week Range: $0.01
▼
$0.03

Volume: 9,705 shs
Average Volume: 75,348 shs
Market Capitalization: N/A

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Stock Analysis Chart Competitors Financials SEC Filings Short Interest Social Media

Get Revelation Biosciences alerts:

Ad Investing Daily

His win rate puts Warren Buffett to shame…

Not long ago I joined Phil Ash for a private one-on-one interview. And during our time together I pulled the covers of my investing system that’s delivered 779 winners and 43,509% total profits since November of 2015… Without a single loss.

Click here now for the full story.

About Revelation Biosciences

Revelation Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of immune system therapeutics and diagnostics. It engages in developing therapeutic product candidates, including GEM-SSI, a potential therapy for the prevention and treatment of surgical sit infection; GEM-AKI, a potential therapy for the prevention and treatment of acute kidney injury; and GEM-CKD, a potential therapy for the prevention and treatment of chronic kidney disease. The company was founded in 2020 and is based in San Diego, California.

REVBW Stock Price History

30 days | 90 days | 365 days | Advanced Chart

REVBW Stock News Headlines

No headlines for this company have been tracked by MarketBeat.com

Receive REVBW Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Revelation Biosciences and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Sector: Medical
Industry: Biotechnology
Sub-Industry: N/A
Current Symbol: NASDAQ:REVBW
CUSIP: N/A
CIK: 1810560
Web: www.revbiosciences.com
Phone: 917 622 5800
Fax: N/A
Employees: 9
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: N/A
Quick Ratio: N/A

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: N/A
Price / Book: N/A

Miscellaneous

Outstanding Shares: N/A
Free Float: N/A
Market Cap: N/A
Optionable: Not Optionable
Beta: N/A

Metaverse Stocks And Why You Can't Ignore Them

Thinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

Key Executives

Mr. James M. Rolke (Age 55)
CEO & Director
Comp: $649.25k
Mr. Chester Stanley Zygmont III (Age 44)
CFO & Corporate Secretary
Comp: $479.14k
Ms. Sandra Vedrick
Vice President of Human Resources & Investor Relations
Ms. Carol Odle
Senior Director of Clinical Projects

Key Competitors

View All Competitors

REVBW Stock Analysis - Frequently Asked Questions

How have REVBW shares performed in 2024?: Revelation Biosciences' stock was trading at $0.0106 at the start of the year. Since then, REVBW stock has increased by 34.9% and is now trading at $0.0143.
View the best growth stocks for 2024 here.
Are investors shorting Revelation Biosciences?: Revelation Biosciences saw a decrease in short interest in April. As of April 15th, there was short interest totaling 1,300 shares, a decrease of 23.5% from the March 31st total of 1,700 shares. Based on an average daily trading volume, of 78,500 shares, the days-to-cover ratio is currently 0.0 days.
View Revelation Biosciences' Short Interest.
How do I buy shares of Revelation Biosciences?: Shares of REVBW stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:REVBW) was last updated on 4/28/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial